We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

BioFire Diagnostics

BioFire Diagnostics, a subsidiary of bioMérieux SA, offers easy-to-use clinical molecular diagnostic solutions based ... read more Featured Products: More products

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Rapid Diagnostic Testing Analyzed in Suspected Meningitis Diagnosis

By LabMedica International staff writers
Posted on 07 Dec 2021
Print article
Image: The FilmArray System Syndromic infectious disease testing impacts duration of empiric antibiotic therapy in suspected bacterial meningitis (Photo courtesy of BioFire Diagnostics)
Image: The FilmArray System Syndromic infectious disease testing impacts duration of empiric antibiotic therapy in suspected bacterial meningitis (Photo courtesy of BioFire Diagnostics)
Bacterial meningitis is a potentially fatal infection of the central nervous system (CNS) that is associated with significant complications including neurologic deficits and epilepsy in the majority of survivors.

Rapid diagnosis and treatment are critical to reducing morbidity and mortality; however, evaluation of suspected meningitis is complex and challenging due to its nonspecific presentation, the limited diagnostic utility of the clinical exam, and the requirement of cerebrospinal fluid (CSF) testing for diagnosis, which traditionally has long turnaround times for culture results and can be affected by antibiotic therapy initiated before performing lumbar puncture.

Medical Doctors at Weill Cornell Medicine (New York, NY, USA) performed a retrospective pre-post intervention study that included adults ≥18 years of age who presented to the emergency department with suspected bacterial meningitis defined by the following criteria: (1) received empiric antibiotic therapy for bacterial meningitis; (2) had lumbar puncture performed in the emergency department; and (3) underwent microbiological testing with CSF culture in the preintervention period and multiplex PCR ME panel testing plus CSF culture in the postintervention period.

The team analyzed the use of the FilmArray meningitis/encephalitis (ME) panel (BioFire Diagnostics, LLC, Salt Lake City, UT, USA), which has been US Food and Drug Administration-approved for use in community-acquired CNS infections, has permitted rapid identification (within 1 hour) of 14 different viral, bacterial, and fungal agents associated with ME in CSF using a multiplex polymerase chain reaction (PCR) system. The scientists gathered data from annual chart reviews over a 3-year period before and after implementation of the ME multiplex PCR panel on February 14, 2017. There were 137 patients in the pre-panel period and 69 patients in the post-panel period.

The investigators reported that the positive detection rate of bacterial pathogens was 3/137 (2.2%) by CSF culture in the pre-multiplex PCR ME panel period and 3/69 (4.3%) by the multiplex PCR ME panel in the post-multiplex PCR ME panel period. There was no difference in the proportion of patients for whom any pathogen was detected by microbiological testing between pre- and post-multiplex PCR ME panel periods (17.5% versus 20.3%). They found that once the panel was implemented, 46% more patients had empiric antibiotic therapy discontinued or de-escalated compared with before the panel was used.

Among 14 patients in the post-multiplex PCR ME panel period for whom a pathogen was identified, three patients had therapy targeted to bacterial pathogens (two S. pneumoniae, one H. influenzae) and 11 to viral pathogens (five enterovirus, three herpes simplex virus 2, three varicella zoster virus). The average turnaround time for the multiplex PCR ME panel was 2.6 hours. In the pre-multiplex PCR ME panel period, the average turnaround time for viral pathogen testing (performed by a viral encephalitis PCR panel on CSF samples) was 71.3 hours.

The authors concluded that implementation of a multiplex PCR ME panel for testing of adult patients who present to the emergency department with suspected bacterial meningitis appears to reduce the duration of empiric antibiotic therapy, time to targeted therapy, and possibly hospital length of stay compared with traditional microbiological testing methods. The study was published in the October, 2021 issue of the journal Open Forum Infectious Diseases.

Related Links:
Weill Cornell Medicine
BioFire Diagnostics


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.